-+ 0.00%
-+ 0.00%
-+ 0.00%

ARRIVENT ANNOUNCES FIRST PATIENT DOSED WITH NOVEL TETRAVALENT MUC16/NAPI2B DUAL TARGET ADC, ARR-002

Reuters·10/12/2026 20:01:00

Please log in to view news